LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis (UC)
50 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07415044·Phase 2·Recruiting·Listed Feb 2026
Clinical Research of Osceola
Clinical research site in Kissimmee, Florida · Orlando Clinical Research Center, 5055 S Orange Ave, Orlando, FL 32809 · (407) 240-7878 · Website
As of July 2026, 16 paid clinical trials are recruiting at Clinical Research of Osceola in Kissimmee, Florida. Active studies at this site cover conditions such as Ulcerative Colitis, Crohn's Disease and Diarrhea. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Clinical Research of Osceola (16)
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
94 locations incl. Peoria
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184931·Phase 3·Recruiting·Listed Sep 2025
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for Ulcerative Colitis
40 locations incl. Scottsdale
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07186101·Phase 2·Recruiting·Listed Sep 2025
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis
28 locations incl. Tucson
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07185009·Phase 3·Recruiting·Listed Sep 2025
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis
91 locations incl. Peoria
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184996·Phase 3·Recruiting·Listed Sep 2025
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for Moderately to Severely Active Crohns Disease
92 locations incl. Dothan
Sponsor: Hoffmann-La Roche
Sex: All·Age: 16 - 80
Code: NCT06819878·Phase 3·Recruiting·Listed Feb 2025
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
for Inflammatory Bowel Diseases
25 locations incl. Lancaster
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Sex: All·Age: 18 - 85
Code: NCT06226883·Phase 2·Recruiting·Listed Jan 2024
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis
38 locations incl. Sun City
Sponsor: Gilead Sciences
Sex: All·Age: 18 - 75
Code: NCT06029972·Phase 2·Recruiting·Listed Sep 2023
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
for Systemic Lupus Erythematosus
9 locations incl. Anniston
Sponsor: AbbVie
Sex: All·Age: 18 - 75
Code: NCT07607964·Phase 1·Recruiting·Listed May 27, 2026
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
for Irritable Bowel Syndrome
15 locations incl. Mesa
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07545759·Phase 2·Recruiting·Listed Apr 2026
Study of DISC-0974-201 in Participants With IBD and Anemia
for Inflammatory Bowel Disease (IBD)
13 locations incl. Scottsdale
Sponsor: Disc Medicine, Inc
Sex: All·Age: 18+
Code: NCT07368972·Phase 2·Recruiting·Listed Jan 2026
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
22 locations incl. Colorado Springs
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184944·Phase 3·Recruiting·Listed Sep 2025
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
for Crohn's Disease
19 locations incl. Sun City
Sponsor: Sanofi
Sex: All·Age: 18 - 75
Code: NCT06637631·Phase 2·Recruiting·Listed Oct 2024
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
for Colitis Ulcerative
19 locations incl. Sun City
Sponsor: Sanofi
Sex: All·Age: 18 - 75
Code: NCT06867094·Phase 2·Recruiting·Listed Mar 2025
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
for Ulcerative Colitis
14 locations incl. Scottsdale
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18 - 80
Code: NCT06636656·Phase 2·Recruiting·Listed Oct 2024
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
for Ulcerative Colitis
8 locations incl. Lancaster
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT06979336·Phase 2·Recruiting·Listed May 2025
More research sites in Kissimmee
- GSK Investigational Site (4 trials)
- Clinical Research of Osceola, LLC (3 trials)
- AdventHealth Celebration (2 trials)
- AdventHealth Kissimmee (2 trials)
- AdventHealth Medical Group Oncology Research at Celebration (2 trials)
- Clinical Research Specialists LLC - Kissimmee (2 trials)
- Ilumina Medical Research (2 trials)
- Ilumina Medical Research LLC (2 trials)
- Alloy Clinical Research (1 trial)
- Alloy Clinical Research LLC (1 trial)
Explore more
Paid clinical trials in Kissimmee, FL · Florida clinical trials